David Piacquad Insider Profile

4 Followers
David Piacquad, SVP BD at Amgen, holds 20.10K shares in Neumora Therapeutics, Inc. (Ticker: NMRA), holds 44.79K shares in Amgen (Ticker: AMGN).
tipranks
David Piacquad

David Piacquad
Amgen (AMGN)
SVP BD

Not Ranked
David Piacquad has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$15M
98.17%
1.83%
A breakdown of David Piacquad's holdings

Insider Roles

Amgen
(AMGN)
SVP BD
Neumora Therapeutics, Inc.
(NMRA)
Director
Roles that David Piacquad holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by David Piacquad

David Piacquad's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Amgen
May 04, 2021
SVP BD
Uninformative Buy
$14.57M
Neumora Therapeutics, Inc.
Jun 14, 2024
Director
Uninformative Buy
$272.15K
List of latest transactions for each holding click on a transaction to see David Piacquad's performance on stock

David Piacquad insider profile FAQ

What is the percentage of profitable transactions made by David Piacquad?
The percentage of profitable transactions made by David Piacquad is ―.
    What is the average return per transaction made by David Piacquad?
    The average return per transaction made by David Piacquad is ―.
      What stocks does David Piacquad hold?
      David Piacquad holds: AMGN, NMRA stocks.
        What was David Piacquad’s latest transaction?
        David Piacquad latest transaction was an Uninformative Buy of ―.
          What was David Piacquad's most profitable transaction?
          David Piacquad’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is David Piacquad's role in Amgen?
            David Piacquad's role in Amgen is SVP BD.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.